Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-20-038879

Options or other derivatives

  • SVP, Chief Scientific Officer acquired 31,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Abrahmsen Lars B. SVP, Chief Scientific Officer 2020-03-24 Grant or award · Stock Option (right to Buy) +31,600 31,600 D
Loading xslF345X03/a4.xml…